Zai Lab Limited (ZLAB)

Zai Lab Limited (ZLAB) is a healthcare company (biotechnology) based in China. The share price is $23.41, down 0.26% on the day, which values the company at $2.92B. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$23.41−0.26% today
Market value
$2.92B
Funk Score
47/100
Against its own history
Below its usual priceusual price $26.85
200-week average
$25.739% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Zai Lab Limited in more detail

ZLAB trades at -11.8× next year's expected earnings, 6.6× sales. Measured against its own history, the price is 13% below what its usual multiples would imply ($26.85) — below its usual price. It sits 9% below its 200-week average of $25.73.

Over the last five fiscal years Zai Lab Limited has compounded revenue 56.5% a year. Its Funk Score is 47 out of 100 (financial strength 3.3, profitability 2.0, growth 10.0, value 3.5, each out of 10).

In its favour: Operating margin is expanding; Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

2 of the superinvestors tracked here hold ZLAB, including Peter Kolchinsky (0.9% of the portfolio), Ron Baron (0.1% of the portfolio).

Superinvestors holding ZLAB

2 of the investors tracked here report a position in their latest 13F filing.

Zai Lab Limited (ZLAB): questions and answers

What is Zai Lab Limited's market cap?

Zai Lab Limited is valued at $2.92B at a share price of $23.41.

Is ZLAB overvalued or undervalued?

Against its own history, ZLAB is below its usual price: the price is 13% below the $26.85 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ZLAB above its 200-week moving average?

No. ZLAB is 9.0% below its 200-week average of $25.73. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Zai Lab Limited growing?

Over the last five fiscal years Zai Lab Limited's revenue grew 56.5% a year.

Does ZLAB pay a dividend?

Zai Lab Limited does not currently pay a regular dividend.

Which famous investors own ZLAB?

In their latest quarterly filings, Peter Kolchinsky (0.9% of the portfolio), Ron Baron (0.1% of the portfolio) hold ZLAB. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Zai Lab Limited (ZLAB) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ZLAB

Underlying data: Yahoo Finance; company filings with the SEC.